News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
276,477 Results
Type
Article (10843)
Company Profile (90)
Press Release (265544)
Section
Business (83580)
Career Advice (304)
Deals (16539)
Drug Delivery (39)
Drug Development (29112)
Employer Resources (51)
FDA (7477)
Job Trends (7017)
News (137759)
Policy (11240)
Tag
Academia (939)
Africa (307)
Alliances (23487)
Alzheimer's disease (500)
Antibody-drug conjugate (ADC) (28)
Approvals (7472)
Arizona (42)
Artificial intelligence (44)
Asia (21302)
Australia (3441)
Bankruptcy (75)
Best Places to Work (5902)
Biotechnology (49)
Breast cancer (32)
C2C Services and Suppliers (29207)
California (987)
Canada (461)
Cancer (279)
Career advice (268)
Cell therapy (59)
China (113)
Clinical research (24020)
Collaboration (113)
Colorado (30)
Compensation (34)
Connecticut (38)
COVID-19 (1234)
Data (254)
Diabetes (43)
Diagnostics (3027)
Earnings (27654)
Employer resources (45)
Europe (44800)
Events (44693)
Executive appointments (96)
FDA (7618)
Florida (121)
Funding (70)
Gene therapy (42)
Georgia (39)
GLP-1 (240)
Government (1334)
Healthcare (8071)
Hotbed/Location (180855)
Illinois (98)
Indiana (106)
Infectious disease (1255)
Inflammatory bowel disease (50)
Interviews (35)
IPO (7461)
Job creations (1255)
Job search strategy (251)
Kansas (28)
Layoffs (141)
Legal (1855)
Liver cancer (31)
Lung cancer (74)
Manufacturing (66)
Maryland (149)
Massachusetts (781)
Medical device (6678)
Medtech (6682)
Mergers & acquisitions (9126)
Metabolic disorders (114)
Michigan (103)
Minnesota (100)
Neuroscience (571)
New Hampshire (34)
New Jersey (361)
New York (308)
NextGen Class of 2024 (1906)
Non-profit (1743)
North Carolina (299)
Northern California (459)
Obesity (67)
Ohio (64)
Opinion (45)
Pennsylvania (308)
People (26993)
Phase I (5660)
Phase II (9487)
Phase III (10602)
Pipeline (73)
Postmarket research (990)
Preclinical (1700)
Press Release (54)
Radiopharmaceuticals (137)
Rare diseases (58)
Real estate (2776)
Regulatory (8492)
Research institute (1008)
Resumes & cover letters (34)
South America (460)
Southern California (390)
Startups (1232)
Texas (97)
United States (4290)
Vaccines (257)
Washington State (105)
Weight loss (49)
Date
Today (13)
Last 7 days (289)
Last 30 days (1441)
Last 365 days (18751)
2024 (13954)
2023 (20023)
2022 (29051)
2021 (30823)
2020 (28652)
2019 (20922)
2018 (15749)
2017 (14336)
2016 (13430)
2015 (15182)
2014 (10923)
2013 (8757)
2012 (9416)
2011 (8988)
2010 (7734)
276,477 Results for "kelyniam global".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Kelyniam Global Releases 3rd Quarter 2023 Financials
Kelyniam Global, a maker of custom cranial implants, announced results for its third quarter ended September 30, 2023.
December 21, 2023
·
2 min read
Business
Strong Fourth Quarter Powers 2023 Kelyniam Financials
Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2023.
March 16, 2024
·
2 min read
Business
Kelyniam Global Releases 2nd Quarter 2023 Financials
Kelyniam Global, a maker of custom cranial implants, announced results for its half year ended June 30, 2023.
August 14, 2023
·
2 min read
Business
Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products
Kelyniam Global, a leading maker of custom cranial implants, announced results for its quarter ended March 31, 2023.
May 22, 2023
·
3 min read
Genetown
Kelyniam Global Announces Record Sales of $3 million in 2022 Financial Statements
Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2022.
March 16, 2023
·
2 min read
Business
Kelyniam Global Announces 3rd Quarter Results
Kelyniam Global, a maker of custom cranial implants, announced results for its quarter ended September 30, 2022.
November 15, 2022
·
2 min read
Press Releases
Tim Hawkins Joins Rephine as CEO to Spearhead Global Leadership
Tim Hawkins Appointed CEO of Rephine to Drive Global Growth and Elevate GMP Audit and Consulting Service
September 23, 2024
·
3 min read
Business
Kelyniam Global Announces 1st Half Results Outstanding Quarter and Sales Momentum into the Second Half
Kelyniam Global, a maker of custom cranial implants, announced results for its quarter ended June 30, 2022.
August 15, 2022
·
2 min read
Infectious disease
Bavarian Nordic Accelerates Mpox Vaccine Production to Respond to Global Emergency
The Danish company on Saturday announced plans to increase production of its vaccine Jynneos on the heels of the World Health Organization last week declaring mpox a global health emergency.
August 19, 2024
·
2 min read
·
Tristan Manalac
Business
Kelyniam Global Announces Record Sales and Operating Profit in 2021 Financial Statements
Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2021.
February 14, 2022
·
3 min read
1 of 27,648
Next
